Atlantic Coastal Acquisition Corp. II (ACAB) to Combine with Abpro in $725M Deal
Atlantic Coastal II (NASDAQ:ACAB) signed a term sheet to enter into a definitive business combination with drug developer Abpro at a valuation of $725 million.
Woburn, Massachusetts-based Abpro is advancing a series of drug candidates to potentially treat COVID, cancer and diabetic blindness. ...READ MORE
